These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25881718)

  • 1. Case Report: Rizatriptan-Induced Ischemic Colitis.
    Fonseka GR; Kurchin A
    Headache; 2015; 55(7):1008-9. PubMed ID: 25881718
    [No Abstract]   [Full Text] [Related]  

  • 2. Rizatriptan induced acute on top of chronic ischemic colitis.
    Alkhatib AA; Gangotena F; Peterson KA
    Am J Gastroenterol; 2009 Oct; 104(10):2643-4. PubMed ID: 19806107
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rizatriptan-induced liver toxicity. Report of a case].
    Fernandez-Atutxa A; Vergara M; Gil M; Dalmau B; Miquel M; Sanchez-Delgado J; Casas M
    Gastroenterol Hepatol; 2013 Apr; 36(4):261-3. PubMed ID: 23084593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic colitis associated with naratriptan and oral contraceptive use: a response.
    Malone TD; Kori SH
    Headache; 2005; 45(10):1418-9; author reply 1419-20. PubMed ID: 16324179
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal infarction during the use of rizatriptan and zolmitriptan: two case reports.
    Fulton JA; Kahn J; Nelson LS; Hoffman RS
    Clin Toxicol (Phila); 2006; 44(2):177-80. PubMed ID: 16615676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rizatriptan: a new milestone in migraine treatment. Closing remarks.
    Pascual J
    Cephalalgia; 2000; 20 Suppl 1():19. PubMed ID: 11078006
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and tolerability of rizatriptan.
    Sakai F
    Cephalalgia; 2000; 20 Suppl 1():16-8. PubMed ID: 11078005
    [No Abstract]   [Full Text] [Related]  

  • 8. Rizatriptan in acute treatment of migraine: update on new comparative data.
    Goadsby PJ
    Cephalalgia; 2000; 20 Suppl 1():10-5. PubMed ID: 11078004
    [No Abstract]   [Full Text] [Related]  

  • 9. Rizatriptan wafer--sublingual vs. placebo at the onset of acute migraine.
    Allen C; Dayno J; Lines C; McCarroll K
    Cephalalgia; 2001 Feb; 21(1):77. PubMed ID: 11298669
    [No Abstract]   [Full Text] [Related]  

  • 10. Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.
    Solomon S; Frishberg B; Hu XH; Markson L; Berger M
    Clin Ther; 2001 Jun; 23(6):886-900. PubMed ID: 11440288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study Groups.
    Block GA; Goldstein J; Polis A; Reines SA; Smith ME
    Headache; 1998; 38(10):764-71. PubMed ID: 11284464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future.
    Mannix LK
    Expert Opin Pharmacother; 2008 Apr; 9(6):1001-11. PubMed ID: 18377342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rizatriptan-Induced Colonic Ischemia: A Case Report and Literature Review.
    Dieringer TD; Crossland DM; Mahl TC
    Am J Gastroenterol; 2018 Jan; 113(1):148-149. PubMed ID: 29311721
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.
    Freitag F; Diamond M; Diamond S; Janssen I; Rodgers A; Skobieranda F
    Headache; 2008 Jun; 48(6):921-30. PubMed ID: 18572432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.
    Savi L; Omboni S; Lisotto C; Zanchin G; Ferrari MD; Zava D; Pinessi L
    J Headache Pain; 2011 Dec; 12(6):609-15. PubMed ID: 21842274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
    Bomhof M; Paz J; Legg N; Allen C; Vandormael K; Patel K
    Eur Neurol; 1999; 42(3):173-9. PubMed ID: 10529545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents.
    Berenson F; Vasconcellos E; Pakalnis A; Mao L; Biondi DM; Armstrong RB
    Headache; 2010 May; 50(5):795-807. PubMed ID: 20546320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.
    Kramer MS; Matzura-Wolfe D; Polis A; Getson A; Amaraneni PG; Solbach MP; McHugh W; Feighner J; Silberstein S; Reines SA
    Neurology; 1998 Sep; 51(3):773-81. PubMed ID: 9748025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineurs.
    Hewitt DJ; Pearlman E; Hämäläinen M; Lewis D; Connor KM; Michelson D; Ceesay P; Assaid C; Bachman R; Harper Mozley L; Dupre N; Strickler N; Mahoney E; Lines C; Ho TW
    Headache; 2013 Jan; 53(1):104-117. PubMed ID: 23078588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rizatriptan reduces vestibular-induced motion sickness in migraineurs.
    Furman JM; Marcus DA; Balaban CD
    J Headache Pain; 2011 Feb; 12(1):81-8. PubMed ID: 20862509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.